Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

July 8, 2024

Study Completion Date

July 8, 2024

Conditions
Actinic Keratosis
Interventions
DRUG

Topical aminolevulinate (10% ALA gel)

10% ALA gel to the entire face, without occlusion, followed by a prespecified incubation period

DEVICE

Red light illumination

Illumination of red light of narrow spectrum of 635 nm with a light dose of approximately 37 J/cm2

Trial Locations (1)

44195

Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

collaborator

Biofrontera Inc.

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER